NASDAQ · Biotechnology

SANA (SANA) Stock

$3.13 -3.69% NASDAQ: SANA Healthcare

Valuation

MetricValue
Price$3.13
Market Cap$871.05M
P/E Ratio-3.66
P/B Ratio5.82
P/S Ratio0.00
EPS (TTM)$-0.96
52-Week High$6.55
52-Week Low$2.58
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-151.55%
ROA-58.51%
ROCE-118.63%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.63
Current Ratio1.89

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-357.0M$-273.0M$-293.0M$-273.0M$-191.0M
Net Profit$-356.0M$-269.0M$-283.0M$-267.0M$-244.0M
EPS$-2.14$-1.43$-1.46$-1.16$-0.96
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.1B$823.0M$565.0M$501.0M$417.0M
Total Liabilities$401.0M$323.0M$278.0M$251.0M$256.0M
Cash$253.0M$177.0M$134.0M$128.0M$72.0M
Borrowings$111.0M$108.0M$104.0M$94.0M$79.0M

Latest News

3 Promising Genomics Stocks to Add to Your Portfolio in 2026 Zacks · Jul 20, 2026 Sana Biotechnology (SANA) Publishes 14 Month Diabetes Cell Therapy Results In NEJM Simply Wall St. · Jul 16, 2026 Sana (SANA) Upgraded to Buy: Here's What You Should Know Zacks · Jul 15, 2026 Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and Durability of Hypoimmune-Modified Islet Cell Transplantation Without Immunosuppression in Type 1 Diabetes GlobeNewswire · Jul 13, 2026 Sana Biotechnology Announces Symposium Presentation at the European Association for the Study of Diabetes (EASD) Annual Meeting 2026 GlobeNewswire · Jul 1, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-251.0M$-290.0M$-254.0M$-223.0M$-144.0M
Investing Cash Flow$-276.0M$190.0M$152.0M$-16.0M$-41.0M
Financing Cash Flow$0$0$0$11.0M$0
Net Cash Flow$135.0M$-75.0M$-50.0M$-6.0M$-55.0M
Free Cash Flow$-281.0M$-311.0M$-274.0M$-257.0M$-145.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-15.80%
Quick Ratio1.29
Interest Coverage—
Return 1Y-37.55%
Return 3Y-46.32%
Return 5Y-79.86%

Ownership

Insiders Held6.51%
Institutions Held82.85%
Institutions Float Held88.62%
Institutional HolderSharesReport Date
FMR, LLC37,430,2842026-03-31
Flagship Pioneering LLC25,001,8562026-03-31
Blackrock Inc.14,240,1752026-03-31
State Street Corporation10,538,0862026-03-31
Canada Pension Plan Investment Board10,221,9002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
DNTH $104.09 +2.44% -17.99 $4.35B 0.00%
INBXInhibrx Biosciences Inc. $81.54 -0.01% -9.72 $1.20B 0.00%
KOD $41.58 -2.16% -8.11 $2.60B 0.00%
NKTR $70.68 -0.13% -6.95 $1.38B 0.00%
NRIX $24.11 -0.17% -6.41 $2.50B 0.00%

About SANA

SANA is led by CEO Steven D. Harr, employs 194 people, headquartered in US, publicly traded since 2021.

SANA stock trades at $3.13 with a market capitalization of $871.05M. The stock is valued at a price-to-earnings (P/E) ratio of -3.66, price-to-book of 5.82, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $2.58 and $6.55, and currently trades 52.2% below its 52-week high.

On profitability, SANA generates a return on equity (ROE) of -151.55%, return on capital employed of -118.63%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides